ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 727621 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 727621; 2) Community: the network communities that were significantly associated with the response to NSC 727621; 3) Molecule: the relationships between components within communities and NSC 727621; 4) MDR: the compounds that were significantly associated with the NSC 727621.

NSC Compound Enrichment Correlation
NSC 679002 2-Butenedioic acid, 2-[3-[(ethoxycarbonyl)methyl]-2,4-dioxopyrimidin-1-yl]-, diethyl ester, cis- 0.0152777849043087 0.4253087
NSC 679005 2-Butenedioic acid, 2,2'-(2,4-dioxopyrimidine-1,3-diyl)bis-, tetraethyl ester 0.0152777849043087 0.37307786
NSC 704888 Fumaric acid, 2-[5-chloro-3-(2-ethoxy-2-oxoethyl)-2,4-dioxo- 1H,3H-pyrimidinyl]-, diethyl ester 0.0152777849043087 0.32528833
NSC 712733 Null 0.0152777849043087 0.22351661
NSC 328410 Camptothecin Derivative 0.0164116791870034 0.43915643
NSC 372155 2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- 0.0164116791870034 0.33891815
NSC 606499 Camptothecin Derivative 0.0164116791870034 0.41616969
NSC 629229 Null 0.0164116791870034 0.1562957
NSC 63984 Cordycepin 0.0164116791870034 0.036663125
NSC 649904 Cyclopentanone, 5-[(4-morpholinyl)methyl]-2-pentylidene-, hydrochloride 0.0164116791870034 0.3152732
Total:49  Current:11    [First] [Prev] [Next] [Last]